VANCOUVER, British Columbia, May 10, 2021 (GLOBE NEWSWIRE) -- Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (the " Company " or " Myconic ") is pleased to announce that the Company has executed and closed an asset purchase agreement (the “ Purchase Agreement ”) for the acquisition of certain clinical assets as an investment (the “ Asset Purchase ”) from Canabo Medical Corporation (“ Canabo ”), a wholly-owned subsidiary of Aleafia Health Inc. (TSX: AH) (“ Aleafia ”). The Company intends to expand the services offered through the network of 14 national medical cannabis clinics (the “ Clinics ”) to include a broader scope of mental health treatments including intravenous ketamine treatments, ketamine-assisted psychotherapy and the administration of esketamine nasal spray. During 2020, the Clinics generated approximately $3.5 million in revenues for Aleafia, which has since increased on an annual run-rate basis due to providing treatments related to the mental health effects of the COVID-19 pandemic.